A detailed history of Cathie Wood (Ark Investment Management LLC) transactions in Amgen Inc stock. As of the latest transaction made, Ark Investment Management LLC holds 74,821 shares of AMGN stock, worth $23.6 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
74,821
Previous 51,666 44.82%
Holding current value
$23.6 Million
Previous $14.7 Million 59.15%
% of portfolio
0.21%
Previous 0.1%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

BUY
$262.75 - $319.31 $6.08 Million - $7.39 Million
23,155 Added 44.82%
74,821 $23.4 Million
Q1 2024

Apr 18, 2024

BUY
$268.87 - $324.56 $13.9 Million - $16.8 Million
51,666 New
51,666 $14.7 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track Cathie Wood's Portfolio

Track Cathie Wood Portfolio

Follow Cathie Wood (Ark Investment Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.